Cell And Gene Therapy Clinical Trial Services Market to Reach $6.22 Billion by 2029 | Key Drivers and Future Outlook
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Cell And Gene Therapy Clinical Trial Services Market In 2029?
The market size for clinical trial services in cell and gene therapy has experienced swift growth in recent years. It is projected to expand from $3.79 billion in 2024 to reach $4.2 billion in 2025, marking a Compound Annual Growth Rate (CAGR) of 10.7%. The acceleration in growth during this historic period is linked to factors such as the higher frequency of chronic ailments, rising demand for efficient treatments for uncommon genetic maladies, enhanced governmental funding for regenerative medicine research, improved comprehension of molecular procedures related to various diseases, and growing awareness about the prospects of personalized medicine.
What Growth Rate Is Forecasted for the Cell And Gene Therapy Clinical Trial Services Market by 2029?
Over the next few years, rapid expansion is anticipated in the market for cell and gene therapy clinical trial services. With a compound annual growth rate (CAGR) of 10.3%, the market is projected to reach $6.22 billion by 2029. The rise in genetic and auto-immune disease cases worldwide, increased funding by the public and private sectors for gene therapy research, new technology utilization, and a surge in genetic defects are all contributing factors to the growth during this forecast period. Key trends expected in this period include the use of artificial intelligence, machine learning adoption, personalized medicine, technological advancements, and gene therapies.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp
Which Key Companies Are Shaping the Future of the Cell And Gene Therapy Clinical Trial Services Market?
Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.
Which Factors Are Driving Demand in the Cell And Gene Therapy Clinical Trial Services Industry?
The growth of the cell and gene therapy clinical trial services market is anticipated to be driven by the increasing prevalence of genetic disorders. These disorders stem from changes in an individual’s DNA or genetic make-up. Factors contributing to the surge in genetic disorders include the rise in genetic testing availability, genetic mutations occurrence, and the high rate of consanguineous marriages. This rising trend of genetic diseases is being tackled by the cell and gene therapy clinical trial services market by promoting innovative treatment development, personalizing treatments for each patient, hastening research conversion into clinical applications, and broadening the treatment prospects for patients with genetic conditions. For example, the Cystic Fibrosis (CF) Foundation, a not-for-profit organization based in the US, reported a substantial increase in the cystic fibrosis affected population in July 2022. In 2022, approximately 40,000 children and adults in the US were affected by cystic fibrosis, and globally, over 105,000 people were diagnosed. Hence, the escalating prevalence of genetic disorders is fuelling the cell and gene therapy clinical trial services market’s expansion.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15535&type=smp
How Is the Cell And Gene Therapy Clinical Trial Services Market Segmented by Several Divisions?
The cell and gene therapy clinical trial services market covered in this report is segmented –
1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services
2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy
3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications
4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Clinical Trial Design And Planning: Protocol Development, Trial Feasibility Studies, Trial Design Consultation, Patient Recruitment And Enrollment Strategy, Risk-Based Monitoring Plans
2) By Supply And Logistic Services: Clinical Trial Supply Chain Management, Cold Chain Logistics, Packaging And Labeling Services, Transportation And Distribution Of Biological Samples, Customs And Import/Export Services
3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting, Regulatory Submission And Documentation, Compliance With GMP (Good Manufacturing Practices), Regulatory Pathway Consultation, Clinical Trial Applications (CTAs)
4) By Data Management And Biostatistics: Clinical Data Management (CDM), Statistical Analysis And Reporting, Clinical Data Monitoring, Data Integration And Validation, Electronic Data Capture (EDC) Solutions
5) By Site Management And Monitoring: Site Selection And Initiation, Clinical Monitoring And Site Visits, Patient Recruitment And Retention, Site Training And Support, Site Performance Monitoring
6) By Other Services: Patient Advocacy And Engagement, Real-World Evidence (RWE) Studies, Post-Trial Services, Medical Writing And Documentation, Clinical Trial Auditing And Inspection
What are the Emerging Market Trends Driving the Growth of the Cell And Gene Therapy Clinical Trial Services Industry?
Leading corporations in the cell and gene therapy clinical trial services market are diversifying their strategies by implementing cutting-edge technology and customer relationship management system technology to enhance productivity and gain an upper hand in the competitive market. The customer relationship management system used by these services enhances the communication and interaction with trial participants, healthcare providers, and other involved parties during the clinical trial phase. For example, in April 2023, AmerisourceBergen Corporation, a healthcare firm based in the US, inaugurated the Cell and Gene Therapy (CGT) Integration Hub. This platform aims to augment connectivity and simplify processes throughout the cell and gene therapy treatment journey. Supported by AmerisourceBergen’s customer relationship management (CRM) system, it aims to streamline the care pathway by offering physicians and patient services teams increased transparency throughout therapy development and delivery. The CGT Integration Hub, equipped with features such as fast-tracked benefits investigation, real-time status updates, and preemptive alerts, is designed to simplify care coordination, reduce obstacles, and enhance the experience for patients and providers throughout the delivery of cell and gene therapies.
Access The Full Report Here:
Which Regions Are Driving Growth in the Cell And Gene Therapy Clinical Trial Services Market?
North America was the largest region in the cell and gene therapy clinical trial services market in 2023. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15535
This Report Delivers Insight On:
1. How big is the cell and gene therapy clinical trial services market, and how is it changing globally?
2. Who are the major companies in the cell and gene therapy clinical trial services market, and how are they performing?
3. What are the key opportunities and risks in the cell and gene therapy clinical trial services market right now?
4. Which products or customer segments are growing the most in the cell and gene therapy clinical trial services market?
5. What factors are helping or slowing down the growth of the cell and gene therapy clinical trial services market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
